O Lebreton

Summary

Affiliation: CHU de Nantes
Country: France

Publications

  1. doi request reprint [Reasons for readmission to hospital after vitreoretinal surgery: 5-year retrospective follow-up]
    O Lebreton
    Service d Ophtalmologie, Centre Hospitalier Universitaire de Nantes, Hotel Dieu, Nantes, France
    J Fr Ophtalmol 32:32-40. 2009
  2. doi request reprint [Ophthalmologic adverse effects of systemic corticosteroids]
    O Lebreton
    Service d Ophtalmologie, CHU de Nantes, Hotel Dieu, Place Alexis Ricordeau, 44093 Nantes Cedex 1, France
    Rev Med Interne 32:506-12. 2011
  3. doi request reprint [Effectiveness of interferon alpha in the treatment of uveitis macular edema refractory to corticosteroid and/or immunosuppressive treatment]
    V Paire
    Service d Ophtalmologie, Hôtel Dieu CHU de Nantes, Nantes
    J Fr Ophtalmol 33:152-62. 2010

Collaborators

  • V Paire
  • M Weber

Detail Information

Publications3

  1. doi request reprint [Reasons for readmission to hospital after vitreoretinal surgery: 5-year retrospective follow-up]
    O Lebreton
    Service d Ophtalmologie, Centre Hospitalier Universitaire de Nantes, Hotel Dieu, Nantes, France
    J Fr Ophtalmol 32:32-40. 2009
    ..To study the etiologies and occurrence rate of readmissions after vitreoretinal surgery...
  2. doi request reprint [Ophthalmologic adverse effects of systemic corticosteroids]
    O Lebreton
    Service d Ophtalmologie, CHU de Nantes, Hotel Dieu, Place Alexis Ricordeau, 44093 Nantes Cedex 1, France
    Rev Med Interne 32:506-12. 2011
    ..The clinical knowledge of the ophthalmologic side effects of systemic corticosteroids is essential to inform our patients, and prevent or detect these complications to treat them appropriately...
  3. doi request reprint [Effectiveness of interferon alpha in the treatment of uveitis macular edema refractory to corticosteroid and/or immunosuppressive treatment]
    V Paire
    Service d Ophtalmologie, Hôtel Dieu CHU de Nantes, Nantes
    J Fr Ophtalmol 33:152-62. 2010
    ..Recent studies have brought out the value of interferon-alpha by demonstrating its low blood rate in affected patients...